<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT UNDER SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 19, 2000
NOVAVAX, INC.
--------------
(Exact name of registrant as specified in its charter)
<TABLE>
<CAPTION>
DELAWARE 0-26770 22-2816046
-------- ------- ----------
<S> <C> <C>
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation or organization) File No.) Identification No.)
</TABLE>
8320 GUILFORD ROAD, COLUMBIA, MD 21046
-------------------------------------- --------
(Address of principal executive offices) (Zip code)
(301) 854-3900
----------------
Registrant's telephone number, including area code
NOT APPLICABLE
-----------------
(Former name or former address, if changed since last report)
<PAGE> 2
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT
On September 19, 2000, the Registrant engaged Ernst & Young
LLP to act as the Registrant's independent certified public
accountants. Ernst & Young LLP replaces PricewaterhouseCoopers LLP,
which firm was dismissed by the Registrant on July 18, 2000. In
accordance with S-K Item 304 (a), the Registrant did not consult with
Ernst & Young LLP during the Registrant's two most recent fiscal
years and any subsequent interim period prior to engaging them
regarding matters that were or should have been subject to Statement
on Auditing Standard No. 50 or any subject matter of a disagreement
or reportable event with the Registrant's former accountant.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
NOVAVAX, INC.
Date:September 22, 2000 By: /s/ John A. Spears
------------------------------
John A. Spears, President and
Chief Executive Officer
